Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study

被引:23
|
作者
Zhou, Xingtong [1 ]
Zheng, Zhibo [2 ]
Chen, Chuyan [3 ]
Zhao, Bangbo [4 ]
Cao, Hongtao [4 ]
Li, Tianhao [4 ]
Liu, Xudong [5 ]
Wang, Weibin [4 ]
Li, Yongning [2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan Wangfujing, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Sci Res Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Thyroid Hurthle cell carcinoma; SEER database; Survival factors; SURVIVAL; RECURRENCE; TUMORS; LEVEL;
D O I
10.1186/s12885-020-06915-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThyroid Hurthle cell carcinoma (HCC) is a rare disease with high risk of invasion and metastasis and poor prognosis. The clinical characteristics, prognosis and treatment of HCC are still controversial, and clinical data are still limited to some case reports. Therefore, understanding the characteristics and survival factors of HCC is clinically necessary.MethodsThis study collected data from HCC patients diagnosed pathologically from 2004 to 2015, including basic population characteristics, tumor characteristics, and epidemiological and survival data. The data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to conduct a population cohort study.ResultsA total of 2101 HCC patients with an average age of 55.4215.27years were enrolled in this study. Of them, 1740 (82.82%) patients had local disease, 245 (11.66%) had regional disease, and 89 (4.24%) had distant disease. Total thyroidectomy was performed in 1669 (79.44%) patients, partial thyroidectomy was performed in 382 (18.18%) patients, and radioactive iodine (RAI) was used in 1155 (54.97%) patients. The 5-year and 10-year cancer-specific survival rate was 95.4 and 92.6%, respectively. The distant disease group had significantly more male patients, multifocal tumors, and extensive tumors compared to the local disease group. Multivariate survival analysis showed that age (P<0.05), SEER stage (P<0.001), and T-stage (P=0.001) had significant effects on survival. There was no significant difference in survival between total and partial thyroidectomy (P=0.078), or between RAI and non-RAI (P=0.733).Conclusion p id=Par Male gender, multifocal tumors, and extended tumors are associated with increased risk of late stage HCC. Age over 45years, distant SEER stage, and late T-stage are independent risk factors for mortality in HCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study
    Tang, Chaopeng
    Zhou, Yulin
    Ge, Silun
    Yi, Xiaoming
    Lv, Huichen
    Zhou, Wenquan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Analysis of clinical features and prognostic factors of lung cancer patients: A population-based cohort study
    Gao, Yuan
    Zhou, Xinjia
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (08) : 712 - 724
  • [33] Epidemiology and prognostic analysis of patients with pancreatic signet ring cell carcinoma: a population-based study
    Nie, Duorui
    Lan, Qingxia
    Huang, Yue
    Fang, Chongkai
    Cao, Yang
    Chen, Yao
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [34] Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study
    Xu, Zihan
    Wang, Li
    Tu, Li
    Liu, Yanyang
    Xie, Xiaoxiao
    Tang, Xiaojun
    Luo, Feng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3801 - +
  • [35] Hurthle Cell Carcinoma A Population-Level Analysis of 3311 Patients
    Goffredo, Paolo
    Roman, Sanziana A.
    Sosa, Julie A.
    CANCER, 2013, 119 (03) : 504 - 511
  • [36] Clinical and molecular prognostic factors in adrenocortical carcinoma
    Libe, Rossella
    MINERVA ENDOCRINOLOGICA, 2019, 44 (01) : 58 - 69
  • [37] Prognostic factors for sublingual gland carcinoma: a population-based Surveillance, Epidemiology and End Results database study
    Qin, Gang
    Wu, Lei
    Li, Chengxia
    Zhang, Qian
    An, Zhongjun
    Qin, Jianhua
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (11)
  • [38] Thyroid Hurthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
    Kure, Shoko
    Ohashi, Ryuji
    CANCERS, 2021, 13 (01) : 1 - 14
  • [39] Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva
    Raspagliesi, Francesco
    Hanozet, Francesco
    Ditto, Antonino
    Solima, Eugenio
    Zanaboni, Flavia
    Vecchione, Francesca
    Kusamura, Shigeki
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 333 - 337
  • [40] Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience
    Oluic, Branisav
    Paunovic, Ivan
    Loncar, Zlatibor
    Djukic, Vladimir
    Diklic, Aleksandar
    Jovanovic, Milan
    Garabinovic, Zeljko
    Slijepcevic, Nikola
    Rovcanin, Branislav
    Micic, Dusan
    Filipovic, Aleksandar
    Zivaljevic, Vladan
    BMC CANCER, 2017, 17